• Structure Therapeutics Chief Scientific Officer Lin Xichen cut holdings via option exercise, ADS conversion, and sales on Sep. 1, 2026.
• Exercised options for 17,817 ordinary shares at USD 0.34 per share.
• Converted 17,817 ordinary shares into 5,939 American Depositary Shares.
• Sold 5,939 American Depositary Shares at weighted-average prices of USD 45.86 and USD 47.2.
• Ended with 228,960 ordinary shares, 0 American Depositary Shares, and options for 125,081 ordinary shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Structure Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001962926-26-000009), on September 02, 2026, and is solely responsible for the information contained therein.